FI970101A - Uusi farmaseuttinen valmiste kivun hallintaan - Google Patents

Uusi farmaseuttinen valmiste kivun hallintaan Download PDF

Info

Publication number
FI970101A
FI970101A FI970101A FI970101A FI970101A FI 970101 A FI970101 A FI 970101A FI 970101 A FI970101 A FI 970101A FI 970101 A FI970101 A FI 970101A FI 970101 A FI970101 A FI 970101A
Authority
FI
Finland
Prior art keywords
pharmaceutical preparation
new pharmaceutical
pct
pain
treatment
Prior art date
Application number
FI970101A
Other languages
English (en)
Swedish (sv)
Other versions
FI970101A0 (fi
Inventor
Arne Folke Brodin
Anders Carlsson
Bengt Goeran Hersloef
Alf Gunnar Martin Nicklasson
Lisbeth Eleonor Marg Rydhag
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI970101A0 publication Critical patent/FI970101A0/fi
Publication of FI970101A publication Critical patent/FI970101A/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1274Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245Amino benzoic acid types, e.g. procaine, novocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI970101A 1994-07-12 1997-01-10 Uusi farmaseuttinen valmiste kivun hallintaan FI970101A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9402453A SE9402453D0 (sv) 1994-07-12 1994-07-12 New pharmaceutical preparation
PCT/SE1995/000760 WO1996001637A1 (en) 1994-07-12 1995-06-21 New pharmaceutical preparation for pain management

Publications (2)

Publication Number Publication Date
FI970101A0 FI970101A0 (fi) 1997-01-10
FI970101A true FI970101A (fi) 1997-01-10

Family

ID=20394703

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970101A FI970101A (fi) 1994-07-12 1997-01-10 Uusi farmaseuttinen valmiste kivun hallintaan

Country Status (30)

Country Link
US (1) US5912271A (fi)
EP (1) EP0767669B1 (fi)
JP (1) JPH10502631A (fi)
KR (1) KR100399522B1 (fi)
CN (1) CN1236759C (fi)
AT (1) ATE202478T1 (fi)
AU (1) AU686414B2 (fi)
BR (1) BR9508373A (fi)
CA (1) CA2193992A1 (fi)
CZ (1) CZ379496A3 (fi)
DE (1) DE69521512T2 (fi)
DK (1) DK0767669T3 (fi)
EE (1) EE9700008A (fi)
ES (1) ES2160712T3 (fi)
FI (1) FI970101A (fi)
GR (1) GR3036745T3 (fi)
HU (1) HUT76809A (fi)
IL (1) IL114446A (fi)
IS (1) IS4397A (fi)
MX (1) MX9700272A (fi)
NO (1) NO970067L (fi)
NZ (1) NZ289954A (fi)
PL (1) PL180504B1 (fi)
PT (1) PT767669E (fi)
SE (1) SE9402453D0 (fi)
SK (1) SK281293B6 (fi)
TR (1) TR199500847A2 (fi)
TW (1) TW410159B (fi)
WO (1) WO1996001637A1 (fi)
ZA (1) ZA955327B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL135060A (en) 1997-09-18 2005-12-18 Skyepharma Inc Sustained release liposomal anesthetic compositions and methods for the preparation thereof
AU752802C (en) 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
SE515982C2 (sv) * 1998-03-06 2001-11-05 Lipocore Holding Ab Användning av en olja-i-vatten emulsion som bärare för framställning av en topikal kräm eller lotion
SE9800729L (sv) * 1998-03-06 1999-09-07 Scotia Lipidteknik Ab Ny topikal formulering I
AU752225B2 (en) 1998-07-17 2002-09-12 Pacira Pharmaceuticals, Inc. Biodegradable compositions for the controlled release of encapsulated substances
EP1043016B1 (en) * 1999-03-30 2014-08-20 Sodic Sa A plant extract based on glycerides,phospholipids and phytosphingolipids, a method for the preparation of this extract and a cosmetic composition containing the same
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
ATE502657T1 (de) * 2001-05-01 2011-04-15 Av Topchiev Inst Petrochemical Zweiphasige, wasserabsorbierende bioadhäsive zusammenstezung
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
CA2445086C (en) 2001-05-01 2008-04-08 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
CA2446060A1 (en) * 2001-05-07 2002-11-14 Corium International Compositions and delivery systems for administration of a local anesthetic agent
JP2004532252A (ja) * 2001-05-31 2004-10-21 スカイファーマ インコーポレーテッド リポソームおよびミクロスフェア中のナノ懸濁物のカプセル化
GB0119859D0 (en) * 2001-08-15 2001-10-10 Qinetiq Ltd Eye tracking system
SE0102933D0 (sv) * 2001-09-04 2001-09-04 Lipocore Holding Ab Lipid carrier
WO2003020318A1 (en) * 2001-09-04 2003-03-13 Lipocore Holding Ab A topical w/o-emulsion composition
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
RU2380092C2 (ru) 2004-01-30 2010-01-27 Кориум Интернэшнл, Инк. Быстро растворяющаяся пленка для доставки активного агента
CA2576158C (en) * 2004-08-05 2020-10-27 Corium International, Inc. Adhesive composition
US8895084B2 (en) 2004-12-23 2014-11-25 Colgate-Palmolive Company Oral care composition containing extract of unoxidized Camellia
WO2009061497A1 (en) * 2007-11-07 2009-05-14 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
KR101562683B1 (ko) * 2007-11-19 2015-10-22 유키지루시 메그밀크 가부시키가이샤 감각 개선제
EP2387394B1 (en) 2009-01-14 2018-05-02 Corium International, Inc. Transdermal administration of tamsulosin
US10111850B2 (en) * 2015-12-01 2018-10-30 Samuel Wilson Ester and cholinesterase inhibitor in long-acting nerve block
BR102014028009B1 (pt) 2014-11-10 2023-04-18 Universidade Federal De Pelotas Composições filmogênicas para bioadesivos anestésicos tópicos (bats) para liberação controlada de princípios ativos e bioadesivos anestésicos tópicos
CN111840553A (zh) * 2019-04-15 2020-10-30 湖州依诺唯新药物制剂有限公司 脂性药物制剂及其应用
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
GB2163956B (en) * 1984-09-08 1988-03-30 Ile De France Percutaneous anaesthetic composition for topical application
GB8712518D0 (en) * 1987-05-28 1987-07-01 Univ Belfast Unit-dose film composition
AU4216089A (en) * 1988-08-12 1990-03-05 Joel E. Bernstein Method and composition for treating and preventing dry skin disorders
FR2661331A1 (fr) * 1990-04-30 1991-10-31 Oreal Composition cosmetique ou dermopharmaceutique contenant des vesicules formees par un melange phospholipides/glycolipides.
JPH05163153A (ja) * 1991-12-19 1993-06-29 Q P Corp スフィンゴ脂質組成物
SE9200952D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
NZ254392A (en) * 1992-06-19 1997-07-27 Univ California Pharmaceutical compositions comprising a sphingoid (e.g. ceramide) compound and optionally cholesterol and a fatty acid
FR2692781B1 (fr) * 1992-06-24 1995-05-05 Sederma Sa Nouvelles compositions cosmétiques contenant des sphingomyélines et autres lipides complexes.

Also Published As

Publication number Publication date
ES2160712T3 (es) 2001-11-16
EE9700008A (et) 1997-06-16
NO970067D0 (no) 1997-01-08
NZ289954A (en) 1997-12-19
EP0767669B1 (en) 2001-06-27
TW410159B (en) 2000-11-01
US5912271A (en) 1999-06-15
SE9402453D0 (sv) 1994-07-12
DE69521512D1 (de) 2001-08-02
PL180504B1 (pl) 2001-02-28
ZA955327B (en) 1996-01-12
AU2994395A (en) 1996-02-09
DK0767669T3 (da) 2001-07-23
JPH10502631A (ja) 1998-03-10
ATE202478T1 (de) 2001-07-15
MX9700272A (es) 1997-05-31
FI970101A0 (fi) 1997-01-10
GR3036745T3 (en) 2001-12-31
KR970704453A (ko) 1997-09-06
IS4397A (is) 1996-12-17
AU686414B2 (en) 1998-02-05
CN1152873A (zh) 1997-06-25
IL114446A0 (en) 1995-11-27
CA2193992A1 (en) 1996-01-25
EP0767669A1 (en) 1997-04-16
PL318172A1 (en) 1997-05-26
IL114446A (en) 1999-08-17
SK281293B6 (sk) 2001-02-12
HUT76809A (en) 1997-11-28
KR100399522B1 (ko) 2004-02-18
PT767669E (pt) 2001-10-30
SK166196A3 (en) 1997-08-06
DE69521512T2 (de) 2001-10-25
WO1996001637A1 (en) 1996-01-25
HU9700056D0 (en) 1997-02-28
CN1236759C (zh) 2006-01-18
NO970067L (no) 1997-01-08
TR199500847A2 (tr) 1996-06-21
BR9508373A (pt) 1997-10-28
CZ379496A3 (en) 1997-06-11

Similar Documents

Publication Publication Date Title
FI970101A (fi) Uusi farmaseuttinen valmiste kivun hallintaan
SE9601421D0 (sv) New composition
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
ATE234090T1 (de) Kombination von duloxetin mit nichtsteroid- entzündungshemmern für die behandlung von schmerz
SE9500422D0 (sv) New oral pharmaceutical dosage forms
DK0880350T3 (da) Behandling af dissemineret sklerose
DK0998287T3 (da) Anvendelse af levobupivacain
IL131086A0 (en) The use of levobupivacaine in paediatric surgery
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
GB9227123D0 (en) Method
SE9401174D0 (sv) New combination
HK1002658A1 (en) Imidazopyridine-azolidinones their preparation and pharmaceutical use
NO975922D0 (no) Ny medisinsk anvendelse
SE9504267D0 (sv) New therapeutic use
ATE268173T1 (de) Methoden zur behandlung von neurombedingten schmerzen
NO984196L (no) FremgangsmÕte for behandling av stoffmisbruk
ATE184487T1 (de) Transdermales therapeutisches system für silatranverbindungen
DE69832796D1 (de) Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen
ES2159479B1 (es) Nuevos indazoles como inhibidores de la ciclooxigenasa-ii